GlassScriptPhysician profile
Terry L Oehler
NPI 1811050305
$4,728.93
in general payments reported to CMS, 2019-2025
10 companies · $2,284 in 2025
The $2,284 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $11.80 · 2023: $230 · 2024: $2,056 · 2025: $2,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,479 · Food and Beverage: $2,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,478.66 |
| Food and Beverage | $2,092.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,525.32 | 2023-2024 | |
| Endo USA, INC. | $1,268.57 | 2024-2025 | |
| Kerecis Limited | $845.03 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $731.19 | 2024-2025 | Krystexxa |
| Trilliant Surgical LLC. | $145.92 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $96.36 | 2023 | Jublia |
| Medtronic, INC. | $75.71 | 2023 | Intellis Adaptivestim |
| Abbott Laboratories | $14.77 | 2024 | Eterna |
| Stryker Corporation | $14.26 | 2023 | Ortholoc 3di |
| Bioventus LLC | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Oehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.